More than meets the eye: Researchers uncover the microbial secrets of dry eye
Researchers have used advanced sequencing technology to determine how the mix of microbes present in patients with healthy eyes differs from the mix found in patients with dry eye. The new work could lead to improved treatments for various eye problems and for diseases affecting other parts of the body.
Microbial communities in and on our body — collectively referred to as the human microbiota — play an essential role in keeping us healthy. Although many studies have focused on microbial communities in our gut, understanding the microbiota present in other body sites is critical for advancing our knowledge of human health and developing targeted interventions for disease prevention and treatment.

“Once we understand the eye microbiota properly, it will improve disease diagnosis at an early stage,” said research team leader Alexandra Van Kley, a professor at Stephen F. Austin State University in Nacogdoches, Texas. “This knowledge can also serve as a catalyst for developing innovative therapies aimed at preventing and treating ocular disease as well as those that affect the central microbiome site: the gut.”
Pallavi Sharma, a graduate student in Van Kley’s lab, will present the research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held March 23–26 in San Antonio.
“Human microbiome research suggests a strong connection between the gut microbiome and the brain and eyes,” said Sharma. “Any alteration in the gut microbiome affects other organs and can lead to disease. Therefore, we are trying to identify patterns of an imbalance between the types of microbes present in a person's ocular microbiome for people with different health problems.”
For the study, the researchers collected eye samples from 30 volunteers using a swab and then performed 16S rRNA sequencing and bioinformatic analysis to determine the microbiome distribution for patients with healthy eyes and those with dry eyes.
The analysis showed that Streptococcus and Pedobacter bacteria species were the most prevalent microbes in healthy eyes while more Acinetobacter species were present in the eye microbiomes of people with dry eye. “We think the metabolites produced by these bacteria are responsible for dry eye conditions,” said Sharma. “We are performing further research to understand the metabolic pathways associated with the Acinetobacter to better understand the disease.”
Next, the researchers would like to explore the gut microbiome of the patients with dry eye to better understand how it related to the eye microbe differences they observed.
Pallavi Sharma will present this research during a poster session from 4:30 to 6:30 p.m. CDT on Tuesday, March 26, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 277) (abstract).
Note: Alexandra Van Kley is listed in the Discover BMB schedule as the presenter, but Pallavi Sharma will be presenting this work.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.